Nuveen, LLC Castle Biosciences Inc Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Nuveen, LLC holds 671,811 shares of CSTL stock, worth $12.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
671,811Holding current value
$12.6 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CSTL
# of Institutions
203Shares Held
26.5MCall Options Held
103KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$57.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$38.4 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$33.7 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$27.5 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.2MShares$22.5 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $493M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...